Cochrane Abstracts
Rosiglitazone for type 2 diabetes mellitus Edited (no change to conclusions)
Rosiglitazone for type 2 diabetes mellitus Edited (no change to conclusions) is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Rosiglitazone for Type 2 Diabetes Mellitus Edited (no Change to Conclusions)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434693/all/Rosiglitazone_for_type_2_diabetes_mellitus_Edited__no_change_to_conclusions_. Accessed 02 February 2023.
Rosiglitazone for type 2 diabetes mellitus Edited (no change to conclusions). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434693/all/Rosiglitazone_for_type_2_diabetes_mellitus_Edited__no_change_to_conclusions_. Accessed February 2, 2023.
Rosiglitazone for type 2 diabetes mellitus Edited (no change to conclusions). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434693/all/Rosiglitazone_for_type_2_diabetes_mellitus_Edited__no_change_to_conclusions_
Rosiglitazone for Type 2 Diabetes Mellitus Edited (no Change to Conclusions) [Internet]. In: Cochrane Abstracts. [cited 2023 February 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434693/all/Rosiglitazone_for_type_2_diabetes_mellitus_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rosiglitazone for type 2 diabetes mellitus Edited (no change to conclusions)
ID - 434693
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434693/all/Rosiglitazone_for_type_2_diabetes_mellitus_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -
